about
Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agentsModerately high folic acid supplementation exacerbates experimentally induced liver fibrosis in ratsMetabolic phenotyping of genetically modified mice: An NMR metabonomic approach.Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infectionDecreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairmentAntiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism.Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice.The level of DING proteins is increased in HIV-infected patients: in vitro and in vivo studies.Measurement of serum PON-3 concentration: method evaluation, reference values, and influence of genotypes in a population-based study.Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation.Interrelationships between paraoxonase-1 and monocyte chemoattractant protein-1 in the regulation of hepatic inflammation.Multifunctional targets of dietary polyphenols in disease: a case for the chemokine network and energy metabolism.Mitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities.Stevia-derived compounds attenuate the toxic effects of ectopic lipid accumulation in the liver of obese mice: a transcriptomic and metabolomic study.Rosiglitazone and fenofibrate exacerbate liver steatosis in a mouse model of obesity and hyperlipidemia. A transcriptomic and metabolomic study.Hypoxia worsens the impact of intracellular triglyceride accumulation promoted by electronegative low-density lipoprotein in cardiomyocytes by impairing perilipin 5 upregulation.Ubiquitous transgenic overexpression of C-C chemokine ligand 2: a model to assess the combined effect of high energy intake and continuous low-grade inflammation.Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients.PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways.A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study.Thermal stability of human plasma electronegative low-density lipoprotein: A paradoxical behavior of low-density lipoprotein aggregation.Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism.Paraoxonase-1 inhibits oxidized low-density lipoprotein-induced metabolic alterations and apoptosis in endothelial cells: a nondirected metabolomic studyThe deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patientsParaoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease.Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice.Treatment of hypertriglyceridemia and HIV: fenofibrate-induced changes in the expression of chemokine genes in circulating leukocytesGenetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection.Differential response of two models of genetically modified mice fed with high fat and cholesterol diets: relationship to the study of non-alcoholic steatohepatitis.Human immunodeficiency virus-infection induces major changes in high-density lipoprotein particle size distribution and composition: the effect of antiretroviral treatment and disease severity.Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease.Expression of cytokine genes in the aorta is altered by the deficiency in MCP-1: effect of a high-fat, high-cholesterol diet.Pitfalls in measuring high-density lipoprotein cholesterol concentrations in HIV-infected patients.The aqueous extract of Hibiscus sabdariffa calices modulates the production of monocyte chemoattractant protein-1 in humans.Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report.Serum paraoxonase-3 concentration is associated with insulin sensitivity in peripheral artery disease and with inflammation in coronary artery disease.Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques.Metformin: a cheap and well-tolerated drug that provides benefits for viral infections.Exploring PPAR modulation in experimental mice.
P50
Q28395443-1EA86E85-B7A9-4DDA-998C-DC810EF09684Q28564329-23CF963C-AB57-4B2D-9F0A-C7E8A3F2DCF6Q33442356-97237BFC-7EF5-43EB-B497-96E3E96121C5Q33657444-F44A9AFF-3CF0-47BE-94D5-88FBF352738BQ33878870-BCFC85DC-6CAC-4C7D-9F1F-E6B431CFE046Q34027872-88F5248B-BFB9-4ECD-9A4C-862EA607544EQ34157876-75B19C03-E64A-42B3-B6E3-B07080C9541EQ34200408-DB44469D-BAD8-4E06-BDEE-94FDD23AC55DQ34776226-851D9CDF-3C67-45BF-8E3D-B5F8115C7347Q35625941-064D6A17-D461-4C09-AC2E-1F64F93AA887Q37707196-91428790-6E65-49BE-A043-996F7CDD0876Q38051914-603EE145-19DC-48CF-9C7F-352549236308Q38093566-40E2AC68-E53E-423F-8B0B-232D47DEB987Q38301930-A8D6E45E-DE73-4D8D-B50A-2AE57A9A207CQ38309329-265CC689-BF07-479D-9150-A65E408CD4ACQ38861588-F15705FC-3FDE-4678-860B-B4EE8B183C22Q39266499-31994837-AD18-4307-ADAB-858CE5CD7BFEQ39970336-B81E588E-5088-4010-9D18-B8278AE2882AQ40793611-E141DFA1-389A-4F96-8F0B-B01FAB692371Q41024442-19665E8A-9397-4403-A6AC-0A6B3C82114CQ41530349-F16EBC71-DC6F-458E-8538-E73E1F3959A7Q42008009-78ACB662-FD44-4E28-9A4B-25CA2D711FB7Q42142758-630498B5-69CA-41BF-AFC5-6380B7F19EF2Q42175449-4180AFC8-5619-48C9-8F18-10D92A190F5DQ42213010-5D32EDAE-D86A-4D5F-ABFA-6C2C93582D96Q42644215-32F7F08F-5626-47AA-AD90-771249938BCBQ42669466-A4F37BBB-6F67-4A3C-ABDF-F04F31B1360AQ42993557-314853A7-7E3D-4783-B338-81340AF62AD3Q43050292-9C2D692F-5CE2-4E5F-BDEF-6180CA06B185Q43060168-6FA9D99F-A581-4786-B31C-4D74BD421504Q43094034-9D261EA7-405B-4105-AC60-CF6845DA3DE7Q43140882-21FE687C-CF21-40D1-8D06-210D7A27C22EQ43225295-BC8E5AC0-CADD-4FFD-95A0-2B78FDB133CDQ43274353-60E81927-A9F4-4AD9-B21D-A3061A32F169Q43277506-82DF7F59-2C63-4AC3-869F-3E7DCF4E6B7CQ43964580-7D350432-918C-462B-85EC-2EFC6E6EB884Q44522315-BC4FF365-360A-4EC3-812B-E96600586BABQ45343506-A9D9095A-F46C-4534-A868-859D48ED4CC3Q45961719-AD14E341-A700-45DF-88CE-E2B526278CB9Q46646535-9FE4FB9A-9360-49C7-8FCB-03B87A721E7D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Rull
@ast
Anna Rull
@en
Anna Rull
@es
Anna Rull
@nl
type
label
Anna Rull
@ast
Anna Rull
@en
Anna Rull
@es
Anna Rull
@nl
prefLabel
Anna Rull
@ast
Anna Rull
@en
Anna Rull
@es
Anna Rull
@nl
P108
P106
P108
P1153
8976842800
P21
P31
P496
0000-0002-8907-7754